C16H22N6O2
Neat
330.39
-20°C
Room Temperature
1675248-19-7, 3-((3R, 4R)-4-methyl-3-(methyl(7H-pyrrolo[2, 3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide, Tofacitinib impurity L, 3-[(3R, 4R)-4-methyl-3-[methyl(7H-pyrrolo[2, 3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanamide, C16H22N6O2, (3R, 4R)-4-Methyl-3-(methyl-7H-pyrrolo[2, 3-d]pyrimidin-4-ylamino)-ss-oxo-1-piperidinepropanamide; Tofacitinib Citrate Impurity 05, MFCD26967966, Tofacitinib impurity T, PT8DR2MS4E, orb3143999, SCHEMBL17718764, 3-((3R, 4R)-4-methyl-3-(methyl(7H-pyrrolo[2, 3-d]pyrimidin-4-yl) amino)piperidin-1-yl)-3-oxopropanamide, CS-M2251, TYD-03338, AKOS037650370, (3R, 4R)-4-Methyl-3-(methyl-7H-pyrrolo[2, 3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanamide, 3-[(3R, 4R)-4-methyl-3-[methyl({7H-pyrrolo[2, 3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanamide, CS-14706, C12680, F789597, 1-Piperidinepropanamide, 4-methyl-3-(methyl-7H-pyrrolo[2, 3-d]pyrimidin-4-ylamino)-beta-oxo-, (3R, 4R)-, 3-[(3R, 4R)-4-methyl-3-[methyl(7H-pyrrolo[2 and 3-d]pyrimidin-4-yl)amino]-1-piperidyl]-3-oxo-propanamide
C[C@@H]1CCN(C[C@@H]1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC(=O)N
3-[(3R, 4R)-4-methyl-3-[methyl(7H-pyrrolo[2 and 3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanamide
InChI=1S/C16H22N6O2/c1-10-4-6-22(14(24)7-13(17)23)8-12(10)21(2)16-11-3-5-18-15(11)19-9-20-16/h3,5,9-10,12H,4,6-8H2,1-2H3,(H2,17,23)(H,18,19,20)/t10-,12+/m1/s1